Syros Price Book Value Ratio from 2010 to 2024
| SYRS Stock | USD 5.40 0.15 2.86% |
Price Book Value Ratio | First Reported 2010-12-31 | Previous Quarter 13.24317799 | Current Value 13.91 | Quarterly Volatility 4.35190873 |
Check Syros Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Syros Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.4 M, Interest Expense of 5.4 M or Selling General Administrative of 18.9 M, as well as many indicators such as Price To Sales Ratio of 21.1, Dividend Yield of 0.0 or PTB Ratio of 13.91. Syros financial statements analysis is a perfect complement when working with Syros Pharmaceuticals Valuation or Volatility modules.
Syros | Price Book Value Ratio |
Latest Syros Pharmaceuticals' Price Book Value Ratio Growth Pattern
Below is the plot of the Price Book Value Ratio of Syros Pharmaceuticals over the last few years. It is Syros Pharmaceuticals' Price Book Value Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Syros Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| Price Book Value Ratio | 10 Years Trend |
|
Price Book Value Ratio |
| Timeline |
Syros Price Book Value Ratio Regression Statistics
| Arithmetic Mean | 3.47 | |
| Geometric Mean | 1.90 | |
| Coefficient Of Variation | 125.56 | |
| Mean Deviation | 3.02 | |
| Median | 1.92 | |
| Standard Deviation | 4.35 | |
| Sample Variance | 18.94 | |
| Range | 13.555 | |
| R-Value | 0.70 | |
| Mean Square Error | 10.39 | |
| R-Squared | 0.49 | |
| Significance | 0 | |
| Slope | 0.68 | |
| Total Sum of Squares | 265.15 |
Syros Price Book Value Ratio History
About Syros Pharmaceuticals Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Syros Pharmaceuticals income statement, its balance sheet, and the statement of cash flows. Syros Pharmaceuticals investors use historical funamental indicators, such as Syros Pharmaceuticals's Price Book Value Ratio, to determine how well the company is positioned to perform in the future. Although Syros Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Syros Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Syros Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Syros Pharmaceuticals Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Syros Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Price Book Value Ratio | 13.24 | 13.91 |
Pair Trading with Syros Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Syros Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Syros Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving against Syros Stock
The ability to find closely correlated positions to Syros Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Syros Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Syros Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Syros Pharmaceuticals to buy it.
The correlation of Syros Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Syros Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Syros Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Syros Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Syros Stock Analysis
When running Syros Pharmaceuticals' price analysis, check to measure Syros Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Syros Pharmaceuticals is operating at the current time. Most of Syros Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Syros Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Syros Pharmaceuticals' price. Additionally, you may evaluate how the addition of Syros Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.